✦ LIBER ✦

Observer bias superimposed on observer variability: Results of a wine tasting

✍ Scribed by Elisabeth Burdick; Keith H. Wittenberg; Thomas C. Chalmers

Book ID: 113297461
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 76 KB
Volume: 12
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(91)90319-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurement of the acromiohumeral interv

Measurement of the acromiohumeral interval on standardized anteroposterior radiographs: A prospective study of observer variability

✍ Gerald Gruber; Gerwin A. Bernhardt; Heimo Clar; Maximilian Zacherl; Mathias Gleh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Effects of Inter- and Intra-Observer Var

Effects of Inter- and Intra-Observer Variability on Echocardiographic Measurements in Awake Cats

✍ Chetboul, V. ;Concordet, D. ;Pouchelon, J. L. ;Athanassiadis, N. ;Muller, C. ;Be 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

CAN THE SYNTAX SCORE BE USED IN CLINICAL

CAN THE SYNTAX SCORE BE USED IN CLINICAL PRACTICE? RESULTS OF A INTER- AND INTRA-OBSERVER VARIABILITY STUDY

✍ Zuily, Stéphane; Goetz, Christophe; Rosencher, Julien; Oulmane, Obay; Mami, Zohe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

New results on fault reconstruction usin

New results on fault reconstruction using a finite-time converging unknown input observer

✍ K.-S. Lee; T.-G. Park 📂 Article 📅 2012 🏛 The Institution of Engineering and Technology 🌐 English ⚖ 494 KB

Some observational results on long-time

Some observational results on long-time variability of stars with magnetic fields

✍ G. Scholz 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 1 views

STATISTICAL ANALYSIS OF POSSIBLE BIAS OF

STATISTICAL ANALYSIS OF POSSIBLE BIAS OF CLINICAL JUDGEMENTS DUE TO OBSERVING AN ON-THERAPY MARKER VARIABLE

✍ FRANCIS BOATENG; ALLAN SAMPSON; BARRY SCHWAB 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

In certain double-blind clinical trials there is the possibility that certain 'marker variables' observable during the trial may in part unblind the trial, even at a subliminal level. At issue is whether or not this potential unblinding biases the investigators' clinical efficacy assessments. This i